Skip to main content
. 2023 Mar 23;108(9):2331–2342. doi: 10.3324/haematol.2022.282030

Figure 4.

Figure 4.

Overall survival according to NRAS or KRAS mutation. Overall survival (OS) according to NRAS mutation in (A) newly diagnosed (ND) patients and (B) relapsed/refractory (R/R) patients. OS according KRAS mutation in (C) ND patients and (D) R/R patients. HR: hazard ratio; CI: confidence interval; mut: mutated; WT: wild-type.